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Summary 
 
 
This observational study closely examined the gross and histopathological lesions 
associated with ovine Johne’s disease in sheep vaccinated as adults with Gudair®. Two 
cohorts of Gudair® vaccinated sheep were used from two separate properties both with 
high OJD mortality rates (>5%). All sheep had been vaccinated outside the recommended 
1 to 4 months of age, mostly as adults. Vaccination injection site lesions were prevalent 
(>39%) in both cohorts of sheep at least 6 months post vaccination. At necropsy, 
lymphatic cording was found to be a good indicator of OJD and highly correlated with 
the formation of a multibacillary lesion. This study indicates the possibility for 
misdiagnosis of OJD based on gross pathology alone and emphasises the necessity for 
histological confirmation. Histopathology from the two cohorts of sheep reports a high 
proportion of multibacillary lesions in one group and a predominance of paucibacillary 
lesions in the other. This suggest the use of the Gudair vaccine could effect the type of 
histological lesion developed in OJD infected sheep vaccinated as adults, however further 
research is necessary to identify additional property factors which could be involved.
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1.1 Introduction 
 Ovine Johne’s disease (OJD) has become a disease of increasing significance for 
the Australian sheep industry, especially within the last 10 years. Rising infection levels 
have created an epidemic and attempts to control and possibly eradicate the disease have 
developed widespread debate among producers and authorities regarding effective 
management of OJD. Much research is underway to further understand the disease and 
consequently develop more effective control methods. 
 Ovine Johne’s disease is characterised by a chronic granulomatous enteritis and 
regional lymphadenitis in sheep caused by Mycobacterium avium subspecies 
paratuberculosis (Mptb) (Clarke and Little, 1996). Infection usually occurs soon after 
birth and is followed by a long incubation period. Clinical signs are commonly not 
evident until at least 18 months of age and affected sheep will experience progressive 
weight loss over a period of weeks to months and eventually die. The slow nature of the 
disease allows carrier animals to spread the disease among the flock for possibly many 
years before it is detected (Sergeant, 2001). This means the disease can be well 
established in a flock before clinical signs are present. Therefore if OJD is suspected in a 
flock it is important to implement preventative measures and continually test for the 
presence of Mptb. 
 Johne and Frothingham first described paratuberculosis as “a peculiar case of 
tuberculosis” in a cow during 1895. Further studies by Bang (1906) confirmed that it was 
not tuberculosis and consequently named it Johne’s disease. Johne’s disease has since 
been found to infect a wide range of both domestic and wild animal species including 
cattle, sheep, goats, deer, rabbits, hares, mice and various species of birds, carnivores and 
macropods (Rolfe, 2003). Within this array of host species exists strain variation of Mptb 
and the particular strain of interest associated with OJD in Australia is the “S” strain 
(Whittington et al., 2000a). 
 OJD is commonly found in varying degrees in most sheep producing countries, 
including New Zealand, United Kingdom, Spain, Iceland and India. In Australia, the first 
diagnosis of OJD occurred in 1980 on a property in the central tablelands region of New 
South Wales (Seamen et al., 1981). The exact origin of the OJD infection in Australia is 
not known although it is suspected that the New South Wales cases originated from 
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imported New Zealand sheep during the 1970s (Denholm et al., 1997). Since its initial 
discovery, OJD has spread to other areas of New South Wales and cases have also been 
identified in Victoria, Tasmania, and South Australia. The most likely cause for spread of 
the disease is via movement of infected stock or by local spread between neighbouring 
flocks (Sergeant, 2001). 
 A 6 year, $40 million National Ovine Johne’s Disease Control and Evaluation 
Program (NOJDP) was implemented in early 1999 to further understand and control the 
disease (Sergeant, 2001). The Australian distribution of OJD is illustrated according to 
nominated zones (Figure 1). OJD is endemic in the Management Area, present at a 
manageable level in the control zone, occurs sporadically in the protected zone and is 
undetected in the free zone. 
 
 
Figure 1. Current OJD Zones in Australia as of July 15, 2003 (NSW Agriculture, 2003). 
 
 At 31 December, 2000, there were 543 known infected flocks in Australia out of a 
potential total of between 2000 and 3700 infected flocks (Sergeant and Baldock, 2002). 
This estimate of flock-prevalence is broad due to some uncertainty about the sensitivity 
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of flock-screening tests for OJD. More than 80% of these infected flocks represent a 
small geographic area of central and southern New South Wales. More recent data as at 
March, 2003 (Table 1) presents a total of 1309 known infected sheep flocks across 
Australia with no infected flocks reported in Western Australia or Queensland. 
 
State Mar-03 Jun-02 Jun-01 
NSW 1123 840 584 
ACT NA 1 2 
VIC 80 45 21 
TAS 41 30 20 
SA 65 15 19 
Total 1309 931 646 
 
Table 1. Number of known infected sheep flocks in Australia (Langwill, 2003). 
 
  
 Within the last decade there has been an alarming increase in the number of 
infected flocks in New South Wales (Figure 2). As a part of the NOJDP, numerous 
research projects have commenced to estimate the full impact of OJD and better 
understand the disease so appropriate control measures can be implemented. 
 
Figure 2. Annual detections of ovine Johne’s disease in New South Wales to December 
2002 (Sergeant, 2001). 
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1.2 Aetiology  
 Mycobacterium avium subspecies paratuberculosis (Mptb) is an acid-fast, weakly 
gram-positive, rod shaped bacillus of 0.5-1.5µm length (Clarke, 1997). Its complex 
mycobacterial cell wall is rich in lipids and is relatively impermeable which provides the 
acid fast property. Mptb differs from other members of the Mycobacterium avium 
complex as it is an obligate pathogen of animals and it does not exist in the environment 
in a replicative form (Whittington and Sergeant, 2001). Mptb is resistant to drying, acid 
conditions and certain disinfectants and can persist in water, soil and faeces for many 
months (Chiodini et al., 1984), however, the survival of the species is entirely dependent 
upon colonisation and dissemination of animals (Whittington and Sergeant, 2001). 
 Mptb is shed in the faeces of infected animals and transmitted to susceptible 
individuals either from contaminated teats during suckling, or from contaminated pasture, 
water or feed (Whittington and Sergeant, 2001). Shedding is particularly high in clinical 
cases, up to 5 x 1012 Mptb per day, and the long incubation period of the disease allows 
for shedding for up to 18 months before clinical signs are evident (Chiodini et al., 1984). 
As few as 102 organisms given orally have been shown to cause microscopic lesions in 
lambs in a study performed by Nisbet et al. (1962), although larger dose rates between 
106 and109 CFU have been shown to be required in other studies to develop clinical cases 
of OJD (Brotherston et al., 1961 and Gilmour, 1965). This indicates that a relatively 
small amount of contaminated faeces is required to infect a large number of susceptible 
animals. Younger sheep, namely lambs, are most susceptible, especially those of a pre-
weaning age (Abbot et al., 2003). 
 There are distinct strains of Mptb and strong links have been found between 
Australian sheep being infected with the sheep(S) strain and other species being infected 
with the cattle(C) strain. Therefore Johne’s disease in sheep and cattle can be considered 
separate (Whittington et al., 2000a).   
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1.3 Pathogenesis 
1.3.1 Clinical 
 The key signs of OJD are chronic weight loss with intermittent diarrhoea (Clarke, 
1997). Weight loss in ruminants is presumed to be a direct result of protein malabsorption 
and loss due to the increased cellular infiltrate and oedema that occur in the intestine 
(Allen et al., 1974a). Compensatory mechanisms of increased protein synthesis by the 
liver are eventually exhausted and clinical signs of wasting are consequently expressed 
(Allen et al., 1974b). Sheep with clinical signs of OJD will have a low body condition 
score and often appear weak (Figure 3). Several implications can present from the disease 
including mortality, loss in feed efficiency and milk yield, decreased fertility, reduced 
slaughter weight at culling and shedding of wool. Diarrhoea has been found to be 
associated with OJD but is not evident in all clinical cases. Faeces can be hard pellets, 
soft and pasty or fluid-like (Carrigan and Seaman, 1990 and Clarke and Little, 1996). 
Due to the lengthy incubation period of the disease, clinical signs are usually expressed in 
older sheep. 
 The typical clinical sign of wasting or ill thrift is common to many other diseases 
and conditions. Some of these include the presence of worm parasites, malnutrition, 
many mineral and vitamin deficiencies, ingestion of plant toxins and carcinoma of the 
small intestine (Hungerford, 1990).    
 
Figure 3. Sheep suspected of being infected with OJD and displaying typical clinical 
signs of wasting. 
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1.3.2 Gross pathology
 At post mortem, most carcasses are emaciated and display diffuse thickening of 
the terminal ileum wall with the mucosal surfaces often presenting a granular appearance. 
(Clarke and Little, 1996 and Clarke, 1997). The intestinal mucosa regularly displays 
prominent traverse ridges and crevices and the serosal surface is usually oedematous with 
cording of the serosal lymphatic ducts (Carrigan and Seaman, 1990, Clarke and Little, 
1996 and Clarke, 1997). Mesenteric and particularly ileocaecal lymph nodes are 
frequently enlarged. Gross lesions are most evident at the terminal ileum adjacent to the 
ileocaecal junction and less apparent both proximally and distally (Carrigan and Seaman, 
1990 and Clarke and Little, 1996). 
 The potential for misdiagnosis of OJD on the presence of gross pathology alone 
has been identified, with the likelihood of experiencing “false positives” (Bush et al., 
2003). This observation presented from a 12 month study (MLA.OJD.023) designed to 
estimate the biological and economic impact of OJD on 12 infected flocks with 
reportedly high mortality rates (exceeding 5%) due to OJD in southern New South Wales. 
Preliminary results illustrated 18.5% of cases with gross and microscopic lesions of 
thickening of the bowel without histopathological verification of OJD. This thickening 
was attributed mostly to serosal oedema, suggested to be due to hypoproteinemia as a 
result of the drought conditions experienced during 2002. This study reinforces the point 
that although properties may have a history of OJD losses, other diseases and conditions 
are also likely to produce similar clinical signs and gross lesions. 
 Hypoproteinemia is a condition commonly associated with gross signs of oedema 
(Radostits et al., 2000). It results from excessive loss of plasma proteins from the blood 
into the gastrointestinal tract due to an osmotic imbalance. Although one of the most 
common causes of chronic protein-losing gastroenteropathy (hypoproteinemia) in 
ruminants is Johne’s disease (Smith, 2002), other causes are possible. Parasite 
infestations and malnutrition with diets low in protein can cause hypoproteinemia 
(Radostits et al., 2000). As severe drought conditions often produce diets low in protein, 
hypoproteinemia can result and consequently display gross thickening of the bowel, 
probably explaining some of the misdiagnosed cases at gross pathological examination 
(Bush et al., 2003). 
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 As there are a number of NOJDP studies involving gross pathology of OJD 
further research is necessary to determine the accuracy of the presence of gross lesions of 
bowel thickening for the diagnosis of OJD. 
 
1.3.3 Histopathology   
 Many studies have discovered two distinct histological lesions of advanced ovine 
paratuberculosis. These include the multibacillary and paucibacillary types and they 
differ in type of cellular infiltrate, degree of mycobacterial colonisation and immune 
response (Clarke and Little, 1996). A majority of cases have a lesion of the multibacillary 
form where the lesion is fully developed with an extensive, diffuse epithelioid 
macrophage infiltrate within the intestinal mucosa and submucosa (Clarke and Little, 
1996, Perez et al., 1996, Perez et al., 1997, Perez et al., 1999 and Sigurdardottir et al., 
1999). These multibacillary lesions have Mptb present in large numbers within the 
epithelioid macrophages (Appendix 1). Sheep with paucibacillary lesions have 
predominantly a lymphocytic infiltrate within the intestine and macrophages present in 
small granulomata accompanied by giant cells. Mptb are either few or undetectable in the 
paucibacillary lesion (Clarke and Little, 1996 and Clarke, 1997) (Appendix 1). 
 These descriptions of the multibacillary lesion are common with ovine pathology 
paratuberculosis type I of Stamp and Watt (1954), group I of Rajya and Singh (1961), 
type I of Reddy et al. (1984), most cases described by Carrigan and Seaman (1990), type 
3b of Perez et al. (1996) and the multibacillary animals studied by Clarke and Little, 
(1996). The paucibacillary lesion is similarly described by Stamp and Watt (1954) (Type 
II), Rajah and Singh (1961) (Group II), Carrigan and Seaman (1990) (the minority of 
cases), Perez et al. (1996) (Type 3c) and in the paucibacillary animals explained by 
Clarke and Little, (1996). 
 The Perez et al. (1996) classification system is used by many studies to describe 
histological lesions of OJD (Appendix 2). Type 1 lesions displayed small granulomata 
containing aggregates of foamy macrophages in the interfollicular and basal areas of the 
ileal Peyer’s patches. Usually these lesions show no sign of Mptb. Type 2 lesions have 
more prominent lesions in the Peyer’s patches and the granulomata have extended into 
the adjacent mucosa with Mptb often present. Type 3 lesions are divided into 3 separate 
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categories. 3A lesions exhibit multifocal and large granulomata in the lamina propria, 
submucosa, serosa and draining lymph nodes. Villi are distended, the mucosa is 
thickened and Mptb are obvious. 3B type lesions display a mosaic-like sheet of 
macrophages and a few giant cells spread diffusely through the lamina propria and 
submucosa causing villous fusion and noticeable thickening of the gut. Mptb are 
abundant in the macrophages (multibacillary) and less so in the lymphoid tissues of the 
intestine and draining nodes. Lesions of the 3C type also show signs of a diffuse 
granulomatous enteritis, but display a consistent lymphocytic infiltrate within the mucosa 
with small, defined granulomata and giant cells scattered throughout. Mptb are 
undetectable or very sparse in these cases (paucibacillary). 
 The type of immune response of the host has also been found to be associated 
with the presence or absence of Mptb (Clarke and Little, 1996, Clarke, 1997 and 
Whittington and Sergeant, 2001). The multibacillary lesion is commonly associated with 
high concentrations of antibody and a weak cell-mediated immune response whilst the 
paucibacillary lesion reflects a high degree of cell-mediated immunity and low antibody 
concentrations. The stages of development and pathogenic mechanisms involved with 
these two types of histological lesions are not clearly understood (Clarke and Little, 1996, 
Clarke, 1997).  
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1.4 Diagnosis of OJD 
 A number of tests are available for the detection of OJD with several advantages 
and disadvantages. There are three main screening tests used in Australia (Sergeant, 
2003). These include the pooled faecal culture (PFC), serology (mainly the agar-gel 
immuno-diffusion (AGID) test) and abattoir surveillance. 
 Pooled faecal culture (PFC) involves pooling faecal samples from a large number 
of sheep into one single sample for culture. Commonly seven pools of fifty sheep are 
used to give a high degree of accuracy. PFC has been shown to be a highly sensitive and 
specific flock test for detection of OJD-infected flocks (Whittington et al., 2000b) and it 
demonstrates a consistently higher flock-sensitivity than serology (Sergeant, 2002). The 
cost and time it takes to receive a final result (>3 months) are distinct disadvantages of 
PFC (Sergeant, 2003).  
  The sensitivity of the main serology test, AGID, is variant depending upon the 
stage of the disease and the selected sample of animals to be assessed. Sensitivity is very 
poor in sheep early in the course of infection and highest in sheep late in the course of 
infection. However, specificity is regularly greater than 99.9% with the AGID test in 
Australian studies (Sergeant, 2003). Due to its poor sensitivity, the use of serology is 
limited to assurance testing or for identification of seropositive animals for further 
confirmatory testing. The enzyme linked immunosorbent assay (ELISA) is a similar 
serology test to AGID and is reported to have similar sensitivity, however the AGID test 
remains more specific (Hope et al., 2000).   
 Abattoir surveillance requires the visual and manual observation of the intestinal 
tract after an animal’s slaughter (Sergeant, 2003). The observation of gross lesions 
suggestive of OJD is confirmed by histopathological examination of tissue samples. 
Infected flocks are identified via trace-back from infected lines of sheep. Abattoir 
surveillance is an effective tool for estimating the regional prevalence and distribution of 
OJD in Australia. With the use of highly educated inspectors and animals of an 
appropriate age (>2 years) it could potentially be used to confirm the absence of OJD on 
a property (Bradley and Cannon, 2003), although there are concerns regarding its 
sensitivity in low prevalence flocks and regions. 
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 The Bradley and Cannon (2003) study aimed to estimate the ability of 3 abattoir 
inspectors to truly diagnose OJD infected sheep using visual and manual examination of 
sheep viscera of 1200 sheep from OJD infected farms. They found the ability of the 
inspectors to detect gross lesions varied from 53% to 87%. Of the three inspectors, the 
best two inspectors (74% and 87% sensitivity) had a high level of agreement between 
their diagnoses whilst the third inspector had not undergone formal OJD inspector 
training. These results reflect a sensitivity level of about 70 - 75% for the ability of 
abattoir inspection to detect histologically positive animals and outline the need for well 
educated inspectors. Meanwhile, for the purposes of a negative assurance scheme, a 
sensitivity level of 50% is proposed to account for the lower level of heavily infected 
animals in low prevalence flocks (Bradley and Cannon, 2003). The examination of sheep 
viscera for gross signs of OJD by abattoir surveillance is a useful tool in supplementing 
other diagnostic testing procedures, however its application for provision of evidence of 
freedom from OJD is more controversial. 
  The effectiveness of the gamma interferon test (IFN-γ) is still being evaluated. 
This test has potential for use in the early detection of infection as it targets cell mediated 
immunity rather than humoral immunity. However, it is unlikely to become a widely used 
diagnostic tool because the test requires technical procedures to be performed within 
hours of sampling and the cost is relatively high (Sergeant, 2003). 
 While there are many different diagnostic tests available, histopathology remains 
the gold standard and is the most common test that provides a definitive diagnosis. A 
disadvantage of histopathology is the necessity to sacrifice the animal for collection of 
tissue samples unless intestinal biopsy is preferred. The culture of biopsies of intestinal 
tissue and associated lymph nodes has been shown to be a sensitive diagnostic tool in 
cattle (Pemberton, 1979, Benedictus and Haagsma, 1986 and Sockett et al., 1992) but has 
only been used experimentally in sheep. Initial results in sheep indicate that fixed biopsy 
tissues of the terminal ileum and associated mesenteric lymph nodes are of good quality 
for histological assessment of OJD (McConnel et al., 2003). Intestinal biopsies would 
have greater use as an experimental tool to further understand the pathogenesis of the 
disease in the live animal.  
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1.5 Measures of control 
 Due to evidence of regional distribution of OJD gathered during the mid-1990s, 
there has been industry pressure to develop state or national programs to control or 
eradicate the disease, with the hope of reducing its spread throughout Australia. Initial 
plans were made by the New South Wales government to control the immediate spread of 
OJD via movement restrictions of known or suspected infected sheep, followed by an 
eradication program. Victoria also implemented an eradication program and soon all 
States had introduced movement restrictions for sheep from known or suspected infected 
flocks (Sergeant, 2001).  
 A proposal for a national eradication program for OJD was discussed in 1997 and 
uncertainty as to whether the disease could be eradicated was identified in The Hussey-
Morris Report (Hussey and Morris, 1998). Based on recommendations from the Hussey-
Morris Report, the deeds of agreement to fund and implement a 6 year, $40 million 
National Ovine Johne’s Disease Control and Evaluation Program (NOJDP) were signed 
by national and state governments in early 1999. The main aims of the program were to 
control the spread of OJD while further research is undertaken to determine the feasibility 
and cost-effectiveness of eradication, including determining the distribution and 
prevalence of the disease (Anonymous, 2000). The Property Disease Eradication Plan 
(PDEP) stipulates a minimum 15 month interval between destocking all infected flocks 
and restocking the property (Taylor et al., 2003). A more recent and continuing study 
evaluating the efficacy of a destocking-restocking strategy to eradiate OJD from infected 
Australian properties has already demonstrated a 46% failure rate. The failure of this 
eradication process is thought to be largely due to the inability to identify OJD free 
replacement stock (Taylor et al., 2003). 
 As discussed in reference to Figure 1, regional zoning of OJD across Australia 
was implemented in July 1999 to reduce the spread of OJD. In more detail, the four zones 
include: i) Residual zones – OJD is endemic but some level of control is in place, ii) 
Control zones – OJD may be present at a manageable level and is actively controlled, iii) 
Protected Zones – OJD occurs only sporadically and eradication measures are enforced 
and iv) Free zones – there are no known or suspected infected flocks (Sergeant, 2001). 
Strict movement conditions of sheep were then enforced depending upon the 
 20
classification of the zone, the flock of origin and the flock of destination. The idea was to 
reduce the movement of sheep from high prevalence flock areas to low prevalence or 
OJD-free flock areas.  
 It has been evident that individual property quarantines and movement restrictions 
have not been effective as first thought in controlling the lateral spread of Mptb in a high 
prevalence environment. It was identified that flocks with undetected infection presented 
a similar trading risk to known infected flocks. Thus in 2003, the NSW Residual Zone 
was reclassified as a Management Area (Figure 4) and individual property quarantines 
and trade restrictions were removed and replaced by a Ministerial Quarantine for the 
whole area. Trade was restricted to low risk animals (either approved vaccinates or sheep 
from assured flocks) and this move was welcomed by producers in the Management Area 
as it removed many of the disincentives for diagnosis and placed the responsibility for 
risk management back on the individual producer (Links et al., 2003). 
 
Figure 4. Current NSW OJD Zones with the Residual Zone reclassified as the 
Management Area (NSW Agriculture, 2003). 
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 The recent registration of the Gudair® vaccine has provided another tool likely to 
be effective in the control of ovine Johne’s disease. Several studies are currently 
underway to evaluate the vaccine and monitor its use and efficacy within Australian 
sheep flocks. One such study, MLA.OJD.009, involves a comparison of sheep vaccinated 
as lambs with non-vaccinated sheep and observes the effects of the Gudair® vaccine on 
immunogenicity, Mptb excretion, mortality, vaccination site lesion persistence and 
animal productivity (Eppleston et al., 2003). Another project, MLA.OJD.015, is a 
longitudinal study monitoring the changes in mortality rates following whole flock 
vaccination with Gudair® of a flock with a high OJD mortality rate (McGregor et al., 
2003). A third study, MLA.OJD.033, has recently commenced looking at changes in 
within-flock prevalence of Mptb shedding following vaccination with Gudair® in high 
and low prevalence flocks (Windsor et al., 2003). 
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1.6 The Gudair® vaccine 
 The Gudair® vaccine contains a suspension of the microorganism, Mptb, strain 
316F, inactivated by heat and adjuvanted with mineral oil in a multiple emulsion (CSL 
Animal Health Australia, 2002). The study by Eppleston et al. (2003) supports the claim 
that one dose (1mL) of the vaccine injected subcutaneously high on the neck behind the 
ear induces good immunological memory and is capable of providing immunity for the 
life of the sheep irrespective of whether IFN-γ responses can be detected in blood.  
 The vaccine was developed and manufactured in Spain (CZ Veterinaria, S.A.). 
The first use of the vaccine in Australia was in December 1999 for experimental purposes 
in the major “intensive” trial (MLA.OJD.009) to determine the effectiveness of the 
vaccine in Australian sheep flocks (Eppleston et al., 2001). Preliminary results led to the 
registration of the vaccine for use in Australia in June 2002. Prior to this, approval to use 
the vaccine in New South Wales was via a permit issued by the National Registration 
Authority. This permit involved certain conditions and was limited to approximately 50 
flocks in New South Wales, all of which had significant mortality rates due to OJD (at or 
exceeding 5%) (Windsor et al., 2003). 
 In New South Wales, registration of the vaccine has provided access for flocks in 
the Control Zone and widened access in the Protected Zone to include: i) all infected 
flocks with an approved Property Disease Management Program (PDMP), ii) all 
monitored at-risk flocks, iii) all Market Assurance Program (MAP) flocks, and iv) all 
flocks trading restocking sheep to the Control Zone or the Management Area (Links et 
al., 2003). 
 Vaccination with Gudair® has demonstrated that it will: i) stimulate the cellular 
and humoral immune systems in a high proportion of vaccinates, ii) delay the onset and 
reduce the incidence of mortalities from OJD in vaccinates, iii) delay the onset and 
reduce the prevalence of shedding of Mptb in vaccinates, and iv) stimulate the 
development of lesions at or in proximity to the site of vaccination in a significant 
proportion of vaccinates (Eppleston et al., 2003). It is important to note that although the 
vaccine is capable of reducing the rate and delaying the onset of OJD-attributable deaths, 
it is not 100% effective against OJD as Eppleston et al. (2003) has already noted six 
deaths in vaccinates beginning at twenty three months of age. Whether eradication of 
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OJD is possible via the use of the Gudair® vaccine is questionable after reports from 
Iceland. Since 1966, vaccination has been compulsory in Iceland in OJD endemic areas 
and in 2001, the infection reappeared on two properties that had been declared 
paratuberculosis free, in an area where vaccination had ceased 3 years earlier (Rolfe, 
2003). 
 Stimulated cellular and humoral immunity in vaccinates has been demonstrated 
by elevated IFN-γ reactions and enzyme linked immunosorbent assay (ELISA) antibody 
levels (Eppleston et al., 2003). The persistence of these parameters in the circulation is 
variable, however, IFN-γ reactors and ELISA antibody levels remain consistently higher 
in vaccinates compared to controls even at 24 months post vaccination.  
 Since the introduction of the Gudair® vaccine into Australia, several research 
projects have been designed to better understand the vaccine’s role in controlling OJD 
within Australian sheep flocks. With a combination of the slow process of the disease and 
the short period for which the vaccine has been available in Australia for experimental 
purposes, the results are limited. Research to date is encouraging and preliminary results 
have answered many questions about the vaccine but there still remain many 
uncertainties and this research has revealed new ideas to explore. 
 A number of issues regarding the use of the Gudair® vaccine in Australian sheep 
flocks have been raised by producers and their advisors. For instance, there is a 
perception by producers that a visible, palpable tissue reaction at or in proximity to the 
site of vaccination is an indicator of successful vaccination (Windsor et al., 2003). This 
particular lesion is expected with the type of adjuvant used in the vaccine and is outlined 
in the product literature as a side effect but there is no evidence supporting the claim that 
the presence of a vaccination site lesion indicates protection against OJD. Vaccination 
site lesions do not seem to occur in all vaccinates. In one particular study, only 42% of 
vaccinates had experienced vaccination site lesions at 2 months post vaccination 
(Eppleston et al., 2003). This figure reached a plateau by 24 months post vaccination 
with 20% of vaccinates having palpable lesions and the average diameter of the lesion 
had not decreased with time as expected according to the product literature. A New 
Zealand study does report a decline in size of the vaccination site lesion over 2 years but 
does not comment on the proportion of vaccinates with vaccination site lesions 
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(Thompson et al., 2002). These lesions may cause further implications at the abattoir as it 
possible for a carcass to require additional trimming depending upon the location of the 
vaccination site lesion at slaughter. 
 Research into the use of different types of adjuvants in commercial vaccines has 
demonstrated a reduction in the local inflammatory response at the site of inoculation 
(Reyes et al., 2002). MONTANIDE® ISA 266 adjuvant offers the same efficiency in 
controlling the OJD infection as Complete Freund’s Adjuvant (CFA) which is used in the 
Gudair® vaccine, but the vaccination site lesion is less pernicious. This is thought to be 
due to a better distribution of the antigen when using the MONTANIDE® ISA 266 
adjuvant. Consequently the use of MONTANIDE® ISA 266 adjuvant could be 
considered as a possible alternative in the preparation of vaccines against OJD.     
 There is also little knowledge on the presence of Gudair® vaccine injection site 
lesions in sheep and their subsequent OJD intestinal lesion type at the gross and 
histological level. The effect of the vaccine on subsequent OJD lesion types either at the 
gross or microscopic level is not clearly understood. There is no evidence to support the 
considered view that vaccination of sheep may increase the likelihood that they will 
develop paucibacillary OJD lesions rather than a multibacillary lesion when they 
eventually ‘breakdown’ (Windsor et al., 2003). 
 It is recommended to vaccinate lambs between the ages of 1 to 4 months, 
although the effect of vaccination in sheep outside this recommended age range is not 
completely known. There is limited data on the effects of the vaccine in older aged sheep 
(e.g. hoggets and mature ewes and wethers), with initial findings reporting no apparent 
effect of the vaccine in reducing the death rate from OJD in adult sheep which were 
presumably exposed to the disease as lambs or weaners (McGregor et al., 2003). Further 
examination into the effects of vaccination in older sheep is warranted. 
 While there is much evidence supporting the effectiveness of Gudair® vaccine 
there are still some controversial issues concerning its use. One major drawback is that it 
does not provide complete protection from infection so it therefore cannot be solely used 
to eradicate the disease. Another concerning issue, is the safety of the vaccine. One 
documented case demonstrates serious reactions after self-inoculation (Windsor et al., 
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2003). More research involving vaccinated sheep could hopefully lead to a better 
understanding and more effective use of the vaccine in Australian sheep flocks. 
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1.7 Conclusion 
 OJD is a disease of increasing importance within Australia. Initial attempts to 
control and eradicate the disease via regional zoning and movement restrictions appear to 
have had limited success. The recent registration of the Gudair® vaccine has provided a 
new approach to the control of OJD. Current research has demonstrated the ability of 
Gudair® to delay and reduce effects of OJD, although it has also revealed new aspects to 
explore. Several studies are continuing in an effort to further understand the disease 
process and establish an effective diagnostic test, with some albeit limited research 
involving vaccinated sheep. The use of some “wasted” and vaccinated adult sheep from a 
cooperating producer for undergraduate necropsy classes has presented an opportunity to 
more closely examine the effects of the vaccine. During the severe drought conditions in 
late 2002, several sheep displayed gross bowel thickening without histological evidence 
of OJD. The ability to attain more sheep from the same “hospital mob” provides an 
opportunity to further examine these findings and possibly determine how accurate the 
observation of gross thickening of the bowel is for field diagnosis of OJD in vaccinated 
sheep. Extra data and tissue samples collected from another project (MLA.OJD.015) also 
allows for a more detailed study of vaccinated sheep. Both cohorts of sheep provide an 
opportunity to conduct an observational study on older vaccinated sheep, with the 
potential to offer new understanding on the vaccine’s impact upon sheep vaccinated 
outside the nominated age range of 4-16 weeks.     
 Such studies could provide information to producers and advisors that will impact 
upon management decisions relating to vaccinated sheep and the use of the vaccine. It 
may also shed some light on the possibility for veterinarians and farmers to misdiagnose 
OJD in the field based on the presence of gross thickening of the bowel. After close 
observation of the gross and histological nature of intestinal lesions, results may add to 
the knowledge of the pathogenesis of Mptb in sheep vaccinated as adults. 
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Materials and Methods 
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2.1 Animals used 
 Sheep used in this observational study were sourced from 2 separate properties. 
Fifty eight sheep (flock 1) were supplied from a property located on the southern 
tablelands of New South Wales near Goulburn. This property is 1929 Ha in size and had 
a total sheep number of 10 575 as of January 1, 2003. It was diagnosed as an OJD 
infected property in 1998 and estimated mortality rates due to OJD in March 2002 were 
about 8%, placing it in the high prevalence category (>5% mortality rate). One 
neighbouring property is known to be infected with OJD, however the status of the other 
7 neighbours is unknown. The impact of drought conditions was noted in October 2002. 
Since then, the producer has experienced an increase in mortalities suspected to be due to 
OJD and he has also noted malnutrition as a problem. The 1998 drop appeared to be the 
most affected generation, especially the wethers. Cell grazing was the preferred grazing 
system but this was altered to a set stocking regime due to the lack of feed at the time of 
drought. This was done to utilise all available pasture and additional feed and water was 
supplied. All sheep were fed either triticale or barley depending upon its availability. 
Sheep used for data collection belonged to the same “hospital mob” described in the 
MLA.OJD.023 project (Bush et al., 2003). They were all of an adult age (3+ years old) 
and were culled from their mobs following the manager’s decision that they displayed 
obvious signs of wasting. 
 As the mortality rate due to OJD was greater than 5% the producer was able to 
apply for use of the Gudair® vaccine. Lambs and one year old sheep were initially 
vaccinated at the end of 2001 and older sheep (2+ year olds) were vaccinated using 
excess vaccine in August/September 2002. As sheep used in this observational study 
were all of an adult age (3+ years old), this means the sheep will have been vaccinated for 
between 6 and 9 months at the time of euthanasia and necropsy. 
 The second property from which sheep were sampled in this study (flock 2) is a 
Merino enterprise also located on the southern tablelands of New South Wales. This 
cohort of sheep was sourced from the same property which is involved with the 
MLA.OJD.015 project (McGregor et al., 2003). Paratuberculosis was diagnosed in the 
flock in 1996 when annual sheep losses from all causes were estimated to be between 3-
5%. Back then the flock grazed 1420 Ha and comprised of about 10 000 adult sheep. 
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Since the diagnosis of OJD and at the time these sheep were used for data collection, the 
enterprise has reduced in size to approximately 1000 Ha and 9000 adult sheep. An 
estimation of the OJD mortality rate from farmer inventory records was 25% in early 
1999. After a detailed investigation of mortalities in this flock by the MLA.OJD.015 
project it revealed an OJD attributable mortality risk to be 16.3% in September 1999. 
 In 1997, a cell grazing system was introduced involving management of the flock 
in mobs of up to 5000 sheep, in paddocks of about 10 Ha, with a change of paddocks 
every 2 to 3 days. Weaner sheep are run separately from adult sheep until they are about 
15 months of age. Shearing occurs in August-September and lambing in September-
October. Ewes are set-stocked during lambing. In the year leading up to the slaughter of 
the sheep used in this trial (September, 2001), significant management changes were 
implemented to combat the increasingly severe drought conditions. Sheep were sold on 
several occasions during the year and the remaining sheep were grazed at increased 
stocking rates to facilitate hand-feeding, provision of water and to enable close 
monitoring of feed intake and changes in body condition. Supplementary feed included 
chopped straw, palm kernels, commercial mineral mix and the best available protein 
supplement.  
 Seventy eight sheep in flock 2 were slaughtered for data collection on 17th 
September, 2001. Sheep slaughtered ranged from 2 to 7 years of age and were vaccinated 
with the Gudair® vaccine according to the dates outlined in Table 2. 
 
Sheep vaccinated 
Date of 
Gudair® 
vaccination
Months since 
vaccination at 
time of 
slaughter 
1999 drop - 2100 lambs 17/05/2000 16 
2460 ewes in lamb and all of an adult 
age 12/08/2000 13 
3500 wethers all of an adult age 19/08/2000 13 
  
     Table 2. Gudair® vaccination dates of sheep from flock 2. 
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 Sheep from both flocks were selected from the producer’s “hospital mob” where 
sheep had very poor body condition scores and were therefore of no commercial value. 
The sheep were considered unfit for transport on welfare grounds. 
 
2.2 Data and tissue collection 
 Collection from flock 1 began on the 24th March 2003 and was completed on the 
2nd June, 2003. At the initial examination, 8 sheep were transported to Elizabeth 
Macarthur Agriculture Institute (EMAI) for a final year vet necropsy class. Three other 
subsequent classes were held at 3-weekly intervals throughout the rest of the semester. A 
similar necropsy class was also held for final year agricultural science students from 
which data and tissue samples were also collected. A Gross Pathology Course held by 
The University of Sydney Post Graduate Foundation at EMAI also provided an 
opportunity to sample a further 20 sheep from flock 1. In total, 58 sheep were used from 
flock 1 for data and tissue collection. 
 Sheep were restrained and gross data was recorded from these sheep including 
age, sex, condition score, confirmation of vaccination (3 hole ear-punch) and presence of 
soft faeces or diarrhoea. The size and location of any vaccination injection site lesions 
was noted. Euthanasia of the sheep was performed with a dose of barbiturate 
(Lethobarb®, Virbac, Peakhurst, Australia) injected intra-venously into the jugular vein. 
Sheep were then weighed and placed in left lateral recumbency to facilitate examination 
of the abdominal contents with the rumen in a ventral position. The animal was skinned 
and the thoracic and abdominal contents were exposed. The terminal ileum was observed 
for any gross signs of thickening and if present, it was graded on a scale of 1(slight) to 
5(severe). A grading of 0 means the appearance of the terminal ileum was normal. If the 
ileocaecal lymph nodes appeared swollen their size was recorded and any signs of 
lymphatic cording were graded on a scale of 1(slight) to 5 (severe). Any other 
abnormalities were also noted. 
 For histopathology, the ileocaecal junction, one ileocaecal lymph node and a 
cross-section of the terminal ileum within 10cm of the ileocaecal junction were taken 
from each sheep and placed in 10% buffered formalin. 
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   Sheep from flock 2 had data and tissues collected at Wollondilly abattoir on 17th 
September, 2001. Data recorded included ear-tag colour/age, size and texture of 
vaccination injection site lesion if present and gross signs of OJD type intestinal lesions 
were graded on a scale of 0 (nil) to 5 (severe). A sheep with 0 gross signs displayed 
intestines as found in the normal state and lymph nodes of normal size while sheep with a 
grading of 1 showed slight serosal oedema and reduced mesenteric fat. A grading of 2 
reflected an increase in serosal thickening of the terminal ileum and a change in size 
and/or texture of the ileocaecal lymph node. Other gradings from 3 to 5 were based on 
the degree of reduction of mesenteric fat in proportion to the increase in serosal 
thickening of the terminal ileum plus lymph node pathology. Any sheep displaying gross 
signs of lymphatic cording along with severe serosal and lymph node changes were 
allocated a grading of 5. For further histological examination, samples were taken of the 
ileocaecal junction, one ileocaecal lymph node and a cross-section of the terminal ileum 
within 10cm of the ileocaecal junction. These tissues were preserved in 10% buffered 
formalin. This data was collected by Helen McGregor, Peter Windsor and Craig Kristo. 
 
2.3 Slide preparation    
  Cross-sections of the terminal ileum, ileocaecal junction and ileocaecal lymph 
node were selected from the sampled tissues and preserved in 10% buffered formalin. 
Cassettes containing the selected tissues were sent into the Veterinary Pathology 
Diagnostic Services at The University of Sydney for further processing. This involved the 
use of a Miles Tek Vacuum Infiltration Processor (VIP) which processes the tissues 
through the following solutions according to a 12 hour schedule; 70% ethanol (2 changes, 
30 minutes each), 95% ethanol (2 changes, 45 minutes each), 100% ethanol (3 changes, 1 
hour each), 100% Xylol (2 changes, 1 hour each) and Paraplast Paraffin wax (3 changes, 
1 ¼ hours each). This procedure removes water and fat from within the tissue and these 
are replaced with paraffin wax. 
 The tissues are then embedded in Paraplast Paraffin wax (melting point 56°C). 
After setting, the tissue blocks formed are sectioned at 5µm and these sections are floated 
on a water bath set at 45°C containing reverse osmosis water and 10mL of non 
 32
inactivated horse serum for adhesion. The sections are then mounted on glass microscope 
slides and allowed to dry overnight at 56°C.  
 Two replica slides of each section were made so one could be stained using 
Whitlock’s Haematoxylin (progressive) and Alcoholic Eosin (Appendix 3a) 
while the other is stained according to the Ziehl-Neelsen method (Appendix 3b). 
 
2.4 Histopathology 
   The slides were then viewed under the microscope and any OJD lesions were 
classified according to the Perez et al. (1996) classification system (Appendix 2). If a 
slide did not present any OJD lesions then it was classed as having no significant lesion 
(NSL). The severity of all the histological OJD lesions was graded on a scale of 1 to 3. A 
grading of 1 showed a mild lesion and a grading of 2 represented a moderate lesion while 
a grading of 3 demonstrated a severe lesion.    
2.5 Data analysis 
 Percentages were calculated for all the data. Any percentages of significance were 
supported using a statistical computer program, Minitab. Contingency tables and chi-
square tests were used to compare differences observed among the histological types of 
the two cohorts of sheep. A number of analyses of variance (ANOVA) were performed to 
determine if any significant correlations were apparent. 
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Results
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3.1 Flock 1 
 
3.1.1 Clinical Examination 
 All 58 Gudair® vaccinated sheep were 3+ years old and this particular cohort of 
sheep included 15 ewes and 43 wethers. All sheep were confirmed to be vaccinated by 
the producer. Only 2 sheep had a body condition score of 3 while the rest had a body 
condition score of 2.5 or less. Thirty eight sheep had their weights recorded with a mean 
weight of 28.7kg and a range of 23.3 – 39.7kg. Of the OJD infected sheep (diagnosed 
histologically) that had their faces examined (40), 53% had soft faeces or diarrhoea.  
 
3.1.2 Gross Lesions   
 Vaccination injection site lesions were found on 45% (26) of the sheep (Figure 5). 
The average size of the lesions was 2.1cm in diameter and ranged from 1 to 5cm. These 
lesions were commonly found 5 to 10cm below the ear on the same side of the neck as 
the site of injection. Enlarged prescapular lymph nodes were palpated in 29% (17) of the 
sheep. 
 Many of the sheep displayed classic gross signs of OJD including a thickened 
terminal ileum, enlarged ileocaecal lymph node and lymphatic cording (Figures 6 & 7). 
No sign of bowel thickening was evident in 25% (12) of the OJD infected sheep and 4 
out of the 10 sheep diagnosed as OJD negative displayed mild signs of bowel thickening. 
Lymphatic cording was present in 44% (21) of the OJD infected sheep and all sheep 
displaying varying degrees of lymphatic cording were diagnosed histologically as having 
OJD. 
 
3.1.3 Histopathology 
 Of the 58 sheep, 83% (48) were diagnosed histologically as being infected with 
OJD and this included 12 (25%) ewes and 36 (75%) wethers. Twice as many 
mulitbacillary (3B) lesions were noted compared to paucibacillary (3C) lesions when 
classified according to the Perez et al (1996) classification system (Figure 8). Over 70% 
of the OJD infected sheep displayed a histological lesion of a severe nature. The 
histological lesion types of the sheep were found to be significantly different (p<0.05)  
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 Figure 5. An example of a vaccination injection site lesion. 
 
 Figure 6. Gross pathology of a severe case of OJD. 
 
 Figure 7. Severe case of lymphatic cording. 
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among sheep displaying lymphatic cording and sheep not displaying lymphatic cording 
(Figure 9). A multibacillary lesion was observed in 85% of sheep displaying lymphatic 
cording. 
 
3.1.4 Alternative diagnoses 
 Table 3 outlines other conditions which were diagnosed in the sheep from flock 1. 
Alternative diagnosis 
No. of OJD 
positive 
sheep 
No. of OJD 
negative 
sheep 
serous atrophy of the fat reserves 1 - 
serosal oedema of the bowel mesentery 2 - 
cysticercosis 1 - 
pizzle rot 1 1 
peritonitis 1 - 
endoparasitism (Trichostrongylus axei) of the abomasum 1 - 
pneumonia presumed to be due to caseous lymphadenitis (CLA) - 1 
CLA subcutaneous lesion 1 - 
blowfly strike 1 1 
adenocarcinoma - 1 
 
Table 3. Alternative diagnoses in sheep from flock 1.  
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 Figure 8. Classification of histological OJD lesions in flock 1. 
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 Figure 9. Histological classification of sheep with and without lymphatic 
 cording. 
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3.2 Flock 2 
3.2.1 Gross Lesions  
 At the time of slaughter the age of the sheep ranged from 2 to 7 years with over 
75% being 3+ years old. Vaccination injection site lesions were present in 39% (30) of 
the sheep on the side of their neck. The size of these lesions averaged 2.6cm in diameter 
and ranged between 0.5 to 5cm. All the sheep diagnosed OJD negative (11) displayed 
gross signs of OJD with a grading of at least 2 with one sheep scoring a severe gross 
signs grading of 5. 
 
3.2.2 Histopathology 
 Of the 78 sheep, 86% (67) were diagnosed histologically as being infected with 
OJD. Other diagnoses were not made. A significantly different proportion of histological 
lesion types were found amongst the OJD infected sheep from flock 2 when compared 
with flock 1. Over twice as many paucibacillary lesions were observed from flock 2 in 
comparison to the number of multibacillary lesions (Figure 10). 
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Figure 10. Classification of histological OJD lesions in flock 2. 
 Histological lesions of a severe nature were noted in 51% (34) of the cases and of 
a moderate nature in a further 28% (19) of the cases. A mild lesion was observed in 21% 
(14) of the OJD infected sheep.    
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Discussion 
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 Ovine Johne’s disease is of increasing significance in the Australian sheep 
industry as it continues to spread in southern and western New South Wales. There is 
debate between producers and authorities on approaches to control OJD with antagonism 
towards the zoning arrangements and quarantine policies. A new OJD control program is 
due to be effective from July, 2004 and it will inevitably include the deregulation of these 
zones. The control of OJD via the newly introduced Gudair® vaccine will become 
increasingly important, as will our need to understand how best to use the vaccine in 
order to maximise its potential. 
 No studies have been completed in Australia to determine how effective the 
vaccine is in sheep vaccinated outside the recommended age range of 1 to 4 months. The 
ability to source sheep from flocks already involved with adjacent studies provided an 
opportunity to closely examine the gross pathology and histopathology in sheep 
vaccinated as adults. It allowed us to add to the knowledge on diagnosis of OJD based on 
gross signs and to further investigate vaccination injection site lesions and their impact on 
gross and histological lesions. 
 
4.1 Effectiveness of Gudair® in adult sheep 
 A large majority of the sheep involved in this study were vaccinated as at least 2 
year olds with the exception of 11 sheep from flock 2 that were vaccinated at 8 months of 
age which is still outside the recommended 1 to 4 months. Diagnosis of OJD based on the 
presence of histological lesions presented very high levels of infection in sheep from both 
properties. Flock 1 demonstrated an OJD diagnosis rate of 83% while 86% of sheep from 
flock 2 were diagnosed with OJD. This indicates that the vaccine is not very effective at 
providing protection against OJD when administered to adult sheep. It is suspected that 
many of these sheep have already been exposed to Mptb as lambs prior to vaccination 
and they are subsequently developing lesions as they get older. Therefore producers 
should expect to continue to see mortalities in high prevalence flocks in the short to 
midterm time period post vaccination if sheep are vaccinated as adults. 
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4.2 Clinical assessment 
 Sheep used for this study were culled from their flock because of concerns that 
they were unproductive and even unsaleable. In combination with knowledge of high 
estimated mortality rates due to OJD, the producers had suspected these sheep had OJD 
due to their “wasted” appearance. Body condition scores and weights were only recorded 
for flock 1 and both these were well below average for fine wool Merinos. A typical fine 
wool Merino would have a body condition score of 3-4 and a body weight of 40-45kg.    
 Of the OJD infected sheep from flock 1 that had their faeces texture examined, 
52.5% had either soft faeces or diarrhoea. This is consistent with findings reported by 
Carrigan and Seaman (1990) and Clarke and Little (1996). Carrigan and Seaman (1990) 
found 50% of a group of unvaccinated OJD infected sheep to have either soft, non-
pelleted faeces or diarrhoea and similarly, Clarke and Little (1996) found 49% of their 
group of unvaccinated OJD infected sheep to have soft faeces or diarrhoea. This conveys 
to producers that the presence of soft faeces or diarrhoea can be indicative of OJD, 
however it is not present in all cases. It is also important to note that soft faeces and 
diarrhoea can be associated with other conditions as observed in 3 out of the 10 OJD 
negative sheep. Therefore soft faeces or diarrhoea is an unreliable clinical indicator of 
OJD.   
 
4.3 Gross lesions and pathology 
 Vaccination injection site lesions were palpated in approximately 40% of the 
sheep from both flocks. This proportion is a little higher than those reported by Eppleston 
et al. (2003) for the time period of 6-16 months post vaccination, however, the lack of 
wool on the sheep after shearing prior to examination may have allowed for better 
detection of these vaccination injection site lesions. In combination with results from 
Eppleston et al. (2003) it is reasonable to suggest that producers can expect about 40% of 
sheep to form palpable injection site lesions post vaccination, irrespective of age of 
vaccination. 
 Further comparisons between sheep with vaccination injection site lesions and 
sheep without vaccination injection site lesions confirmed no significant results. There 
was no significant correlation between the presence of a vaccination injection site lesion 
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and the gross pathology or histological lesion type. This indicates that the presence of a 
vaccination injection site lesion is unlikely to influence the degree of bowel thickening or 
the formation of a particular type of histological lesion. The presence of a palpable 
vaccination injection site lesion does not appear to be a useful indicator that adult sheep 
vaccinated with Gudair® have sufficient protection against the effects of OJD to alter the 
clinical outcome as questioned by Windsor et al. (2003). 
 Enlarged prescapular lymph nodes were found on 29% (18) of the sheep from 
flock 1. Both vaccination injection site lesions and enlarged prescapular lymph nodes are 
required to be trimmed from the carcase in the abattoir and could add an extra cost to 
carcase preparation. However, feedback from processors indicates that these lesions 
would not present an issue as Australian carcases are routinely heavily trimmed.  
 While many of the OJD infected sheep displayed the classic signs of bowel 
thickening, an enlarged ileocaecal lymph node and lymphatic cording, 25% of the OJD 
positive sheep had no sign of bowel thickening. Additionally, 4 out of the 10 sheep 
diagnosed as OJD negative displayed mild signs of bowel thickening. This presents the 
possibility for misdiagnosis of OJD as discussed by Bush et al. (2003) based solely on 
gross signs of bowel thickening. Similarly, Carrigan and Seaman (1990) discuss the 
possibility of overlooking mild gross changes in the intestines and attributing the 
emaciation to another cause. This data also supports the Bradley and Cannon (2003) 
study that expresses the need to have educated inspectors on the abattoir floor to be able 
to detect OJD based on gross pathology. These findings indicates that “false positives” 
based on gross pathology are likely to be common and that confirmation of diagnosis via 
histopathology is a necessity. Bowel thickening can be caused by other conditions and is 
not only indicative of OJD. For example, hypoproteinaemia can result in malnourished 
animals which have been starving during a drought. These concepts are important for 
producers, veterinarians and inspectors to understand when diagnosing OJD.  
 As all 21 sheep from flock 1 that displayed lymphatic cording were diagnosed 
with OJD, lymphatic cording is considered to be a very good diagnostic indicator of OJD.  
This supports reports by Carrigan and Seaman (1990), Clarke and Little (1996) and 
Clarke (1997). Corded lymph vessels were often noted on the serosal surface of the 
thickened intestines by Carrigan and Seaman (1990) and lymphatic cording is regarded as 
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a common gross lesion in a review by Clarke (1997). A significant correlation was found 
between the presence of lymphatic cording and the subsequent lesion type. It was found 
that sheep displaying lymphatic cording had a multibacillary lesion in 85% of the cases. 
Therefore these sheep are likely to be large excretors of Mptb. Similar prominent cording 
of the serosal lymphatic ducts was reported in 83% of mutlibacillary animals and 71% of 
paucibacillary animals in a study of 45 unvaccinated OJD infected sheep by Clarke and 
Little (1996). In our study, 54% of the multibacillary and 20% of the paucibacillary 
vaccinated OJD infected sheep displayed lymphatic cording. Is this difference an 
influence of vaccination? 
 There was no significant correlation found for either of our flocks between the 
type of histological lesion and the degree of bowel thickening from flock 1 or the degree 
of gross signs from flock 2. For example, sheep with severe gross pathology were not 
found to have one particular type of histological lesion while sheep with mild gross 
pathology were not found to have a different type of histological lesion. This suggests the 
degree of inflammation and not the type of histological lesion influences the visual 
appearance of bowel thickening.  
 
4.4 Histopathology 
 A significant finding was the difference between the types of histological lesions 
in the 2 different cohorts of sheep (Figure 11). Two thirds of the OJD infected sheep from 
property 1 had a histological lesion of a multibacillary type and one third had a lesion of 
the paucibacillary type, whereas the reverse was observed with OJD infected sheep from 
property 2. This raises the question, is this observational difference attributable to the use 
of the vaccine? For example, is it possible the vaccine is capable of having an impact 
upon the immune system during the developing stages of the lesion, thus forming a 
particular type of histological lesion in sheep vaccinated as adults? 
 Results from Clarke and Little (1996) find 69% (31) of a group of unvaccinated 
sheep to have multibacillary lesions and 31% (14) to have paucibacillary lesions which 
are similar proportions to those from property 1. Carrigan and Seaman (1990) 
experienced 88% (44) of a group of unvaccinated sheep to have multibacillary lesions 
and 12% (6) to have paucibacillary lesions. These observations indicate that a greater 
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proportion of multibacillary animals compared to paucibacillary animals is to be expected 
in an OJD infected population as observed in flock 1.  
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 Figure 11. Comparison of types of histological lesions in OJD infected sheep from flock 
1 and 2. 
 
 What possible reasons are there to explain the reversal of this multibacillary to 
paucibacillary ratio between property 1 and property 2. Being an observational study, 
there are a number of factors which need to be considered when attempting to determine 
why this difference has occurred between the two properties in this study. 
 Firstly, the genotype of the sheep could have impacted upon the results as both 
properties have studs and therefore have their own bloodlines and these may react 
differently to the vaccine. However, they are both fine wool Merino breeders and the 
explanation of this hypothesis would require extensive research on the genetics of 
immunological responses to OJD.  Sheep from flocks on property 2 may well be worthy 
candidate flocks for such a study. 
 Secondly, the time of data collection could have affected the type of histological 
lesion. Data collected from sheep from property 2 in 2001 was at the beginning of a 
severe drought whereas data collected from sheep from property 1 was at the end of the 
drought. The drought influenced management changes to the grazing protocol of both 
properties. Property 1 changed from a cell grazing system to a set stocking regime 
thereby decreasing stocking rates while property 2 increased stocking rates by restricting 
grazing to a smaller area to facilitate hand feeding. This could well have intensified 
exposure to infection on property 2. Current drought feeding advice promotes semi-lot 
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feeding to reduce energy expenditure of grazing, however this may increase challenge of 
Mptb in OJD infected flocks. Further research on the benefits of lot-feeding versus the 
effect of increased OJD exposure in droughts appears to be of importance. 
 Thirdly, post-exposure vaccination in older sheep indicates the vaccine could be 
acting like a booster. In the case of property 2, the increased challenge from Mptb from a 
more intensive grazing protocol and a higher initial property infection status, could 
increase or boost the immune response and direct developing lesions in a paucibacillary 
direction. However, in sheep where the disease is already too far advanced and the 
antigenic load is too great, a sufficient immune response is not created and the lesion 
develops in a multibacillary direction. 
 Fourthly, the length of time for which the sheep have been vaccinated before the 
data was collected could also be a factor. Sheep from property 1 had only been 
vaccinated for 6-9 months prior to euthanasia whereas sheep from property 2 were 
vaccinated 13-16 months prior to slaughter. This may suggest that the sheep from 
property 2 had more time for repeated stimulation of the immune system with a greater 
degree of challenge from the Mptb and this may lead to the more likely formation of a 
paucibacillary lesion. 
 These results raise the question as to whether the vaccine is capable of being used 
as a tool in high prevalence flocks of adult sheep to induce the formation of a 
paucibacillary lesion in sheep already infected with OJD? This would therefore reduce 
Mptb excretion rates and contamination levels and consequently reduce the risk of 
exposure of the infection to newborn lambs or other sheep. 
 Nevertheless, this is only one interpretation of these observations and as indicated 
more research is necessary to support these hypotheses.  
 
4.5 Limitations and Further Research 
 There were several limitations to this study due to the availability of resources 
and a restricted time period. Sheep from flock 2 were slaughtered in September, 2001. I 
was relying upon the records of the gross pathology of the sheep and was unable to obtain 
precise and accurate data as recorded for flock 1. A more detailed study on the gross 
pathology of the sheep from flock 2 would have been performed. However, the 
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histopathology from flock 2 was very useful for comparison with results from flock 1. 
Pooled faecal culture (PFC) would have been useful to examine Mptb excretion rates 
however the cost of this procedure at $100 per culture was considered too excessive for 
this study. 
 It would have been appropriate to compare these results with unvaccinated sheep 
but this was simply impractical. As sheep were sourced from commercial operations that 
were aiming to control and reduce OJD prevalence, producers considered it would not be 
effective to leave any sheep unvaccinated. Therefore unvaccinated sheep were unable to 
be sourced as the entire flock had already been vaccinated on each property. A major 
study in vaccinated lambs is being conducted on 3 properties in the Bathurst region 
(MLA.OJD.009), consisting of 200 lambs vaccinated with Gudair® while another 200 
lambs were left unvaccinated on each property. Preliminary results from this study have 
recorded 67 deaths from the unvaccinated sheep and 6 deaths from the vaccinated sheep. 
All 6 vaccinate mortalities have had multibacillary lesions while 88% (59) of the 
unvaccinated sheep mortalities have had multibacillary lesions (P. Windsor, personal 
communication). It would be interesting to examine the pathology of the unvaccinated 
lambs as well as the vaccinated lambs from the MLA.009.OJD trial so a comparison can 
be made with the results from the vaccinated adults in this study.  
 Preliminary results from a current study on property 2 (MLA.015.OJD) have 
provided some insight into the level of multibacillary animals and paucibacillary animals 
pre-vaccination. The creditability of this data is limited because the sample number is 
low, however it still provides some information which relates to this study. Prior to 
vaccination, a small group of sheep was sampled from the same “hospital mob” that was 
used in this study and tissues were submitted for histopathology.  A similar proportion of 
multibacillary lesions and paucibacillary lesions were found in these sheep pre-
vaccination when compared to sheep vaccinated as adults in this study from property 2. 
Tissues were sampled in April 2000 and the histopathology classification indicates 64% 
(14) with paucibacillary lesions and 36% (8) with multibacillary lesions. This indicates 
that there may be a particular property effect that is inducing the formation of a greater 
number of paucibacillary lesions instead of the vaccine. A closer examination of the 
differences between these 2 properties may reveal certain pre-disposing risk factors 
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which impact upon the immune system differently and stimulate the formation of 
different types of histological lesions.         
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Conclusion 
 
 This study has provided new information on the effects of the Gudair® vaccine in 
sheep vaccinated as adults. It has demonstrated that within a short time frame post 
vaccination, the vaccine is not very effective at providing protection against OJD in adult 
sheep which have most likely been exposed to infection as lambs. The study has 
emphasised the potential for misdiagnosis of OJD based on gross signs and stresses the 
importance of histopathology to confirm OJD infection. Producers can expect 40% of 
vaccinated sheep to develop vaccination injection site lesions, however, these lesions do 
not provide an indication of protection against OJD. Further, this study identified 
differing proportions of multibacillary lesions and paucibacillary lesions from 2 different 
cohorts of sheep from 2 different properties. This raises the question, is the vaccine 
capable of inducing a paucibacillary lesion in sheep vaccinated as adults and 
consequently reducing excretion rates of Mptb? Preliminary pre-vaccination data from 
another study suggests that a property or genotype effect rather than the vaccine may be 
influencing the high proportion of paucibacillary lesions experienced on property 2. 
Further research will be necessary to explore the property or genotypic characteristics 
and/or vaccine capabilities that could encourage the formation of paucibacillary lesions in 
OJD infected sheep and thus minimise excretion rates of Mptb and limit the spread of 
OJD within Australia. 
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Appendix 1 
 
Multibacillary Lesions – 3B 
 
 
 
Figure 12. A Haematoxylin and Eosin stain of a section of the mucosa of the terminal 
ileum showing extensive infiltration between the villi of pink epitheliod macrophages in 
the lamina propria (Mag. x100). 
 
 
Figure 13. A Ziehl-Neelsen stain of a section of the mucosa of the terminal ileum 
showing the presence of thousands of rod shaped Mptb in the epitheliod macrophages 
(Mag. x100). 
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Paucibacillary Lesions – 3C 
 
 
  
Figure 14. A Haematoxylin and Eosin stain of a section of the mucosa of the terminal 
ileum presenting a pleiomorphic appearance. This results from a multicellular immune 
response and includes macrophages as well as other cell types like lymphocytes and 
histiocytes (Mag. x100). 
 
 
Figure 15. A Ziehl-Neelsen stain of a section of the mucosa of the terminal ileum 
showing the absence of the rod shaped Mptb in the lesion (Mag. x100). 
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Appendix 2 
 
 
The Perez et al. (1996) OJD lesion classification system 
Type 1 Lesions 
• Location  
• only in the lymphoid tissue, never in the intestinal mucosa. 
• PPs: interfollicular spaces, in the basal zone, less often at the apex 
• MLNs: paracortex or interfollicular area, related to subcapsular or 
peritrabecular sinuses (MLN less often affected than PP) 
• Type 
• granulomata formed by macrophage-like cells (nuclei large and clear with 
obvious nucleoli, abundant slightly foamy cytoplasm, lightly stained by H&E and 
sometimes with clear vacuoles) often with small numbers of lymphocytes and 
cells with elongated nuclei 
• no AFB are seen. 
Type 2 Lesions 
• Type 
• granulomata well delineated, round, variable in number, never enough to 
result in diffuse enteritis 
• AFB occasionally seen in granulomata in mucosa, but not in PPs/MLNs. 
• Location 
• PPs: granulomata in a row from the most basal zone of the interfollicular area 
to the apex, penetrating into the lamina propria. Granulomata in the villi are 
always associated with granulomata in an adjacent PP 
• MLNs: similar to type 1 lesions. Less frequently seen than those in PPs and 
always smaller in size 
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Type 3 Lesions 
• Granulomatous lesions affect PPs, associated mucosa and mucosa that is not 
associated with lymphoid tissue. There are 3 subtypes: 
Subtype 3a 
• Type 
• Lesions sporadic, multi-focal 
• AFB are seen in granulomata in the mucosa  
• Location 
• PPs and associated mucosa: 
- lesions are similar to type 2 
- granulomata in the lamina propria are larger, extend from PPs, involve more 
villi, cause enlargement of villi 
• Areas of mucosa not associated with PP’s: 
- granulomata are small and well delineated in lamina propria of  villi and/or 
the basal area 
• Submucosa and serosa: 
- foci of inflammatory cells (mostly lymphocytes and macrophages) are seen 
around lymphatic and blood vessels 
• MLNs: granulomatous lesions  
Subtype 3b (Multibacillary) 
• Type 
• Diffuse granulomatous enteritis creates a mosaic formed by macrophages, 
epithelioid cells, a few giant cells (2-3 nuclei), small numbers of lymphocytes 
and other leukocytes 
• AFB in abundance, numbers in mucosa > than in lymphoid tissue. 
• Location 
• PPs: granulomata in the interfollicular areas, follicles and domes, with 
infiltrates giving a mosaic-like appearance, among lymphoid aggregates 
• Mucosa:  
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- villi thickened, apices flat and wide, fused, fewer crypts due to infiltration 
- in some sheep the mucosa is less thickened, epithelioid cells are seen in the 
villi (mostly the apex) and diffuse enteritis is due to confluence of numerous 
small granulomata 
• Submucosa: 
- lymphocyte and plasma cell infiltrates, initially perivascular, but extending to 
the muscular layer, with lymphatics dilated and thrombi composed of 
macrophages seen within 
• Serosa: 
- Lymph-angitis/angiectasis, perivascular lymphocyte/plasma cell aggregates  
• MLN’s: 
- multi-focal or diffuse granulomatous lymphadenitis 
- subcapsular sinuses usually contain macrophages 
- serosal lesions similar to those in the gut serosa 
Subtype 3c (Paucibacillary) 
• Type 
• diffuse granulomatous enteritis, but the cell types differ from type 3b 
• AFB rarely seen, and then only in small numbers. 
• Location 
• PPs: 
- lesions similar to type 3b, but with pyknotic macrophages and giant cells 
• Mucosa: 
- diffuse granulomatous enteritis, but the predominant cells are lymphocytes in 
the lamina propria of the villi and the basal area; macrophages are seen among 
the lymphocytes either scattered or in small, well defined granulomata of up 
to 20-25 cells 
• Submucosa: 
- frequently oedema, with variable numbers of lymphocytes and plasma cells 
• Serosa: similar to type 3b 
• MLNs: 
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- multifocal granulomata in the paracortical and interfollicular areas 
- Langhans giant cells (some with >30 nuclei) may be present 
- pyknotic macrophages and perivascular infiltrates are seen in the serosa of the 
LNs 
 
NSL lesions – No significant lesion 
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Appendix 3a 
 
Haematoxylin and Eosin (H&E) staining method 
 
Solutions:  Whitlock’s Haematoxylin (after Mayer) 
  Scott’s Blueing solution 
  Alcoholic Eosin 
Method: 
1. Dewax section and bring to water – 2 changes of xylol (3 minutes each) and 2 changes 
of 100% ethanol (2 minutes each). Place sections in Alcoholic piric acid for 15 minutes to 
remove the acid haematin precipitate. Wash in running tap water until the yellow colour 
is removed. 
2. Stain in Haematoxylin for 3 minutes. 
3. Wash in running tap water for 2 minutes. 
4. Scott’s Blueing solution for 2 minutes. 
5. Wash in running tap water for 2 minutes. 
6. Rinse in 70% ethanol. 
7. Eosin for 28 seconds. 
8. Dehydrate rapidly to 100% ethanol. 
9. Clear in several changes of xylol. 
10. Mount in DPX. 
 
Results: Nuclei – blue 
  Background – orange/pink 
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Appendix 3b 
 
Ziehl – Neelsen staining method (1882, 1883) 
 
 This staining is used to demonstrate the presence of Mycobacteria sp. bacillus 
(acid fast bacilli). M. tuberculosis is the tubercle bacillus and is difficult to demonstrate 
because of the lipid capsule surrounding it. Carbol fuchsin is forced into the tissue with 
heat and is then removed by acid or alcohol. The stain I removed from almost all 
structures except the lipid capsule which resists decolourisation. This gives rise to the 
name acid fast bacteria. 
Solutions: 1. Carbol Fuchsin: 
    Basic Fuchsin (5g) 
    100% Ethanol (50mL) 
    5% Phenol (500mL) 
    (5g phenol in 500mL distilled water) 
Dissolve the basic fuchsin in absolute alcohol then add to the phenol solution. Mix well. 
Filter before use. 
 
  2. Methylene blue (0.1%): 
    Methylene blue (0.1g) 
    Distilled water (100mL) 
 
  3. Acid alcohol: 
    Hydrochloric acid (0.5mL) 
    70% Ethanol (100mL) 
Method: 
ALWAYS USE A POSITIVE CONTROL 
1. Dewax and bring sections to water – 2 changes of xylol (3 minutes each), 2 changes of 
100% ethanol (2 minutes each), 2 changes of 95% ethanol (30 seconds each) and 2 
changes of 70% ethanol (30 seconds each). Wash in running tap water for 2 minutes. 
2. Filter carbol fuchsin onto slide. 
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3. Heat to steaming, leave for 2 minutes, repeat heating and leave for 10 miniutes. 
4. Wash in water. 
5. Differentiate in acid alcohol until sections are pale pink. 
6. Wash in water. 
7. Counterstain in 0.1% methylene blue for 10-15 seconds. 
8. Wash in water. 
9. Dehydrate, clear and mount in DPX. 
 
Results: Acid fast bacilli – red 
  Nuclei – blue 
  Other tissue – pale blue 
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